News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
683,806 Results
Type
Article (38984)
Company Profile (277)
Press Release (644545)
Section
Business (203835)
Career Advice (1987)
Deals (35357)
Drug Delivery (84)
Drug Development (80772)
Employer Resources (168)
FDA (16085)
Job Trends (14800)
News (344480)
Policy (32430)
Tag
Academia (2530)
Alliances (49041)
Alzheimer's disease (1217)
Approvals (16005)
Artificial intelligence (122)
Bankruptcy (352)
Best Places to Work (11479)
Biotechnology (196)
Breast cancer (109)
Cancer (948)
Cardiovascular disease (82)
Career advice (1657)
Cell therapy (208)
Clinical research (63959)
Collaboration (334)
Compensation (171)
COVID-19 (2522)
C-suite (82)
Data (903)
Diabetes (138)
Diagnostics (6106)
Earnings (84352)
Employer resources (146)
Events (109052)
Executive appointments (254)
FDA (16543)
Funding (298)
Gene therapy (153)
GLP-1 (562)
Government (4319)
Healthcare (18659)
Infectious disease (2600)
Inflammatory bowel disease (102)
Interviews (308)
IPO (16274)
Job creations (3623)
Job search strategy (1415)
Layoffs (409)
Legal (7848)
Lung cancer (156)
Manufacturing (157)
Medical device (13150)
Medtech (13155)
Mergers & acquisitions (19117)
Metabolic disorders (369)
Neuroscience (1459)
NextGen Class of 2024 (6497)
Non-profit (4463)
Northern California (1262)
Obesity (219)
Opinion (176)
Patents (96)
People (56148)
Phase I (19845)
Phase II (28158)
Phase III (21025)
Pipeline (254)
Postmarket research (2553)
Preclinical (8445)
Radiopharmaceuticals (234)
Rare diseases (187)
Real estate (5888)
Regulatory (21453)
Research institute (2307)
Resumes & cover letters (349)
Southern California (1128)
Startups (3560)
United States (12068)
Vaccines (539)
Weight loss (161)
Date
Today (226)
Last 7 days (918)
Last 30 days (3180)
Last 365 days (35551)
2024 (30913)
2023 (40074)
2022 (51173)
2021 (55712)
2020 (54087)
2019 (46541)
2018 (35019)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (187)
Asia (37032)
Australia (6039)
California (2853)
Canada (1195)
China (217)
Colorado (126)
Connecticut (126)
Europe (79291)
Florida (408)
Georgia (102)
Illinois (312)
Indiana (184)
Kansas (95)
Maryland (538)
Massachusetts (2333)
Michigan (144)
Minnesota (254)
New Jersey (851)
New York (863)
North Carolina (673)
Northern California (1262)
Ohio (129)
Pennsylvania (772)
South America (1091)
Southern California (1128)
Texas (399)
Utah (82)
Washington State (328)
683,806 Results for "protokinetix inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Research Paper Incorporating ProtoKinetix AAGP® Submitted to Scientific Journal for Publication
ProtoKinetix, Incorporated, a clinical-stage biomedical company, announced the submission of a research paper describing cell characterization, graft evaluation, and yield of islet-like cells differentiated from patient-derived iPSCS for the treatment and eventual cure of Type-1 Diabetes for publication in Cell Stem Cell, a peer-reviewed scientific journal published by Cell Press.
June 6, 2023
·
3 min read
Drug Development
ProtoKinetix Successfully Completes Phase 1 Clinical Trials for the Treatment of Type 1 Diabetes in Islet Cell Transplants
ProtoKinetix, Incorporated ( www.protokinetix.com ) (the “Company” or “ProtoKinetix”) (OTCQB: PKTX ), a clinical-stage biomedical company, today announced that the University of Alberta has successfully completed Phase 1 clinical trial enrollment for the treatment of type 1 diabetes in islet cell transplants.
July 20, 2022
·
2 min read
BioMidwest
ProtoKinetix Announces Annual General Stockholder Meeting Will Be Held Virtually Only
ProtoKinetix, Incorporated (www.protokinetix.com) (the “Company” or “ProtoKinetix”) (OTCQB: PKTX), a clinical-stage biomedical company, today announced that it will hold its Annual General Meeting of the Stockholders of the Company (“AGM”) virtually with no option to attend the AGM in person due to ongoing COVID-19 concerns.
January 14, 2022
·
1 min read
BioMidwest
ProtoKinetix Announces Selection of AAGP® Candidate Formulations for Treatment of Dry Eye Disease
ProtoKinetix, Incorporated today announced that it has selected two formulations of its Anti-Aging Glycopeptide (AAGP®) product to be advanced into preclinical efficacy testing for the topical treatment of dry eye disease and ocular inflammation.
November 23, 2021
·
4 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Business
ProtoKinetix and IQVIA Partner to Support Development of AAGP® Product in the Treatment of Ocular Conditions
ProtoKinetix, Incorporated (www.protokinetix.com) (the “Company” or “ProtoKinetix”) (OTCQB: PKTX), a clinical-stage biomedical company, today announced its collaboration with IQVIA (NYSE: IQV) to accelerate development of AAGP® (PKX-001) in ocular conditions, specifically Dry Eye Disease and Wet and Dry forms of Age-related Macular Degeneration.
May 12, 2021
·
3 min read
Press Releases
Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc.
Verrica Pharmaceuticals Inc. today announced the settlement of litigation with Dormer Laboratories, Inc. (“Dormer Labs”).
July 1, 2024
·
5 min read
Lophos Holdings Inc. Announces the Completion of Securities Purchase Agreement with ThreeD Capital Inc.
Lophos Holdings Inc. (CSE: MESC) (“Lophos” or the “Company”), a Canadian bioscience company focused on the cultivation and sale of Lophophora williamsii (“Peyote”) and ThreeD Capital Inc. (CSE: IDK) (OTCQB: IDKFF) (“ThreeD”), a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, are pleased to announce the completion of its previously announced Securities Purchase Agreement (the “Agreement”).
June 20, 2024
·
4 min read
Press Releases
Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. Announce Business Combination to Form Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”)
October 8, 2024
·
14 min read
Press Releases
CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium
November 4, 2024
·
1 min read
1 of 68,381
Next